Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mydecine Innovations Group (TSE:MYCO)
CNQX:MYCO
RESEARCH TOOLSreports
Mydecine Innovations Group (MYCO) Stock Price & Analysis
85 Followers
MYCO Stock Chart & Stats
Day’s RangeC$0.02 - C$0.02
52-Week Range― - ―
Previous CloseC$0.02
Volume79.00K
Average Volume (3M)N/A
Market Cap
C$788.51K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mydecine Innovations Group News
PremiumCompany Announcements
Mydecine Corrects Financials, Affects Company Valuation
PremiumCompany Announcements
Mydecine Settles Debts, Shares to Trade on Aquis
PremiumCompany Announcements
Mydecine Settles Debt with Equity Issuance
PremiumCompany Announcements
Mydecine Settles Debt with Equity Issuance
PremiumCompany Announcements
Mydecine Chooses Equity Settlement to Preserve Capital
MYCO FAQ
What was Mydecine Innovations Group’s price range in the past 12 months?
Currently, no data Available
What is Mydecine Innovations Group’s market cap?
Currently, no data Available
When is Mydecine Innovations Group’s upcoming earnings report date?
Mydecine Innovations Group’s upcoming earnings report date is May 14, 2024 which is in 14 days.
How were Mydecine Innovations Group’s earnings last quarter?
Currently, no data Available
Is Mydecine Innovations Group overvalued?
According to Wall Street analysts Mydecine Innovations Group’s price is currently Overvalued.
Does Mydecine Innovations Group pay dividends?
Mydecine Innovations Group does not currently pay dividends.
What is Mydecine Innovations Group’s EPS estimate?
Mydecine Innovations Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mydecine Innovations Group have?
Currently, no data Available
What happened to Mydecine Innovations Group’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mydecine Innovations Group?
Currently, no hedge funds are holding shares in TSE:MYCO
---
Mydecine Innovations Group Stock Smart Score
Company Description
Mydecine Innovations Group
Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.
---
Technical Analysis
---